Definitive Contract 75N95019C00042

Award Date 8/4/19
Potential Completion Date 8/3/24
Potential Value $3.3M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,572,707.00 definitive, cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA) to Research Triangle Institute (RTI International) for analytical chemistry and stability testing services related to substance use disorder treatment drugs. The contract has an ultimate completion date of August 3, 2029. The contract supports the development and validation of analytical methods, reference standard preparation, physical and chemical characterization, quality...
The National Institute on Drug Abuse (NIDA) awarded a Cost Plus Fixed Fee delivery order contract to Research Triangle Institute (RTI International) for $206,477.33 to provide synthesis and distribution of drugs of abuse and related compounds. The period of performance is from June 9, 2020 to June 8, 2021, with a potential completion date of June 8, 2022. This order is not associated with a set-aside program. RTI International is an independent, non-profit research organization with extensive...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a one-year delivery order contract valued at $212,912.30 to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for the synthesis and distribution of drugs and related compounds in support of NIDA's research programs. This task order is part of a larger indefinite delivery vehicle (N01DA-18-8944) that does not utilize any...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health within the Department of Health and Human Services, awarded a $2.28 million cost-plus-fixed-fee delivery order contract to Research Triangle Institute International (RTI) for the synthesis and distribution of drugs of abuse and related compounds. Under the terms of task order N01DA-18-8944 issued against the NIDA Drug Supply Program indefinite-delivery/indefinite-quantity contract vehicle, RTI will provide...
This is a $1,885,675.00 definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to Research Triangle Institute (RTI International), a non-profit research organization. The contract, which does not have a set-aside designation, is for purity specifications, storage, and distribution of medications to support NIDA's research and development activities. As the prime contractor, RTI International will provide a...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $1,261,383.00 cost-plus-fixed-fee task order to Research Triangle Institute (RTI) International, a non-profit research organization. This task order, designated 75N95021F00001, was issued under IDIQ contract 75N95019D00042 for the "Preparation and Distribution of Research Drug Products". The task order does not have a set-aside designation. RTI...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Research Triangle Institute (RTI) International, a nonprofit research institute. The contract, valued at $2,800,866.00, is for the Synthesis and Distribution of Drugs of Abuse and Related Compounds from June 9, 2024 to June 8, 2027. This is a delivery order under task order 75N95024F00001 (TO6), contract number N01DA-22-8944. The...
Research Triangle Institute (RTI) International has been awarded a cost-plus-fixed-fee delivery order against a Blanket Purchase Agreement with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) for $1,495,510. The delivery order is for the period March 20, 2023 through March 19, 2024 and involves the preparation and distribution of research drug products to support NIDA's mission. No set-aside designation was used for this award. RTI will perform the work at its...
This is a cost-plus-fixed-fee delivery order task order awarded by the National Institutes of Health National Institute on Drug Abuse (NIH NIDA) to the non-profit research organization Research Triangle Institute (RTI) International. The $2,291,030.00 contract is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 9, 2018 to June 8, 2019. The contract does not have a set-aside designation. RTI has experience providing a range of...
This contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (HHS-NIH-NIDA) to Research Triangle Institute - doing business as R T I International is for the synthesis and distribution of drugs of abuse and related compounds from June 9, 2023 to June 8, 2024 under Task Order 75N95023F00001 (TO4) of major program N01DA-22-8944. The contract type is a delivery order with a place of performance in Research Triangle Park, North...

The National Institute on Drug Abuse (NIDA) awarded a $3,296,055.47 cost-plus-fixed-fee contract to the Research Triangle Institute (RTI International) for analytical chemistry and stability testing of treatment drugs for substance use disorders. The contract has a performance period from August 4, 2019 to August 3, 2020, with an ultimate completion date of August 3, 2024. The contract is not designated as a set-aside.

RTI International, a non-profit research institute, will provide technical services including analytical method development, reference standard preparation, quality control testing, and stability studies to support NIDA's medications development program. Subcontractors include Evoqua Water Technologies for water treatment systems, Specgx (Mallinckrodt Pharmaceuticals) for pharmaceutical products, and Agilent Technologies for analytical instruments and laboratory equipment. This work supports NIDA's mission to develop new treatments for drug addiction and prepare data packages for regulatory submissions to the FDA.

Generated 7/2/24, 2:16 PM